Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Plasmodium Immunotherapy for Advanced Malignant Solid Tumors

NCT04165590 is registered in ClinicalTrials.gov with CAS Lamvac Biotech Co., Ltd. as lead sponsor.

NCT NCT04165590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04165590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Plasmodium Immunotherapy for Advanced Malignant Solid Tumors
Lead sponsor
CAS Lamvac Biotech Co., Ltd.
Phase
Phase 1/2
Overall status
Recruiting
Start date
October 24, 2019
Completion date
October 31, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignant solid tumor